Mid-term outcomes after aortic valve neo-cuspidization with glutaraldehyde-treated autologous pericardium
The Journal of Thoracic and Cardiovascular Surgery Feb 28, 2018
Ozaki S, et al. - Researchers here evaluated the mid-term results of the aortic valve neo-cuspidization (AVNeo) procedure with the longest follow-up of 118 months. In patients with various aortic valve diseases, the mid-term outcomes of AVNeo utilizing autologous pericardium were satisfactory.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
